BDBM571932 2-{[(alphaR)-6-[(4S)- 4-(2,2-dimethyl- propyl)-2,5-dioxo- imidazolidin-1-yl]- spiro[3.3]heptan- 2-yl]oxy}pyridine- 3-carboxamide::US11447487, Example 25

SMILES CC(C)(C)C[C@@H]1NC(=O)N([C@H]2C[C@@]3(C[C@@H](C3)Oc3ncccc3C(N)=O)C2)C1=O

InChI Key InChIKey=UZVVWARWLVSBQV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 571932   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM571932(2-{[(alphaR)-6-[(4S)- 4-(2,2-dimethyl- propyl)-2,5...)
Affinity DataIC50: 10nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent